Jie-Yi Shi

2.7k total citations
31 papers, 1.6k citations indexed

About

Jie-Yi Shi is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Jie-Yi Shi has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Immunology and 9 papers in Surgery. Recurrent topics in Jie-Yi Shi's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Jie-Yi Shi is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Jie-Yi Shi collaborates with scholars based in China, Ethiopia and United States. Jie-Yi Shi's co-authors include Qiang Gao, Jia Fan, Xiaoying Wang, Jian Zhou, Meng Duan, Zhen‐Bin Ding, Xiaoming Zhang, Liu‐Xiao Yang, Ai‐Wu Ke and Liangqing Dong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jie-Yi Shi

28 papers receiving 1.5k citations

Peers

Countries citing papers authored by Jie-Yi Shi

Since Specialization

Citations

This map shows the geographic impact of Jie-Yi Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie-Yi Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie-Yi Shi more than expected).

Fields of papers citing papers by Jie-Yi Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie-Yi Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie-Yi Shi. The network helps show where Jie-Yi Shi may publish in the future.

Co-authorship network of co-authors of Jie-Yi Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Jie-Yi Shi. A scholar is included among the top collaborators of Jie-Yi Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie-Yi Shi. Jie-Yi Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GPC-3 and AXL are essential factors and therapeutic targets for hepatocellular carcinoma 2025 ·SHILAP Revista de lepidopterología ·Chao Qiu, Jie-Yi Shi, Yan Su, (unknown), Shuye Zhang, Yanling Feng, Xiaoyan Zhang, Xiaowu Huang, Jianqing Xu	1
2	Calcium and Gastrointestinal Disorders: Mechanistic Insights and Therapeutic Interventions 2025 ·International Journal for Vitamin and Nutrition Research ·Yingdong Zheng, (unknown), (unknown), Jie-Yi Shi, (unknown), (unknown)	0
3	Differential expression pattern of CC chemokine receptor 7 guides precision treatment of hepatocellular carcinoma 2025 ·Signal Transduction and Targeted Therapy ·Jie Qin, Qianyi Gong, (unknown), (unknown), Yifei Cheng, (unknown), Di Zhu, (unknown), Yuye Zhang, (unknown), (unknown), (unknown), (unknown), Qian Li, Binbin Liu, Y. S. Zhu, Zuoyun Wang, Jie-Yi Shi, Shuang–Jian Qiu, (unknown)	0
4	Mining the interpretable prognostic features from pathological image of intrahepatic cholangiocarcinoma using multi-modal deep learning 2024 ·BMC Medicine ·Guangyu Ding, Weimin Tan, Youpei Lin, Ling Yu, (unknown), Shu Zhang, Jie-Yi Shi, Rongkui Luo, (unknown), Xiaoying Wang, Jian Zhou, (unknown), Muyan Cai, Bo Yan, Qiang Gao	9
5	ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma 2024 ·Molecular & Cellular Proteomics ·(unknown), Ke Gao, (unknown), Yin Li, Yingcheng Wu, Liangqing Dong, Zijian Yang, Jie-Yi Shi, (unknown), Qiang Gao, Haojie Lu, Shu Zhang	4
6	Artificial intelligence-based pathological analysis of liver cancer: Current advancements and interpretative strategies 2024 ·PubMed ·Guangyu Ding, Jie-Yi Shi, (unknown), Bo Yan, Xi-Yang Liu, Qiang Gao	0
7	NLRC3 High Expression Represents a Novel Predictor for Positive Overall Survival Correlated With CCL5 and CXCL9 in HCC Patients 2022 ·Frontiers in Oncology ·(unknown), Jie-Yi Shi, (unknown), (unknown), Youpeng Ding, (unknown), Binbin Liu, Qiang Gao, Jie Qin, Chunmin Liang	8
8	Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma 2021 ·Journal of Hepatology ·Guangyu Ding, Jiaqiang Ma, Jing‐Ping Yun, Xing Chen, Ling Yu, Shu Zhang, Jie-Yi Shi, (unknown), Yuan Ji, Xiaoying Wang, Weimin Tan, Kefei Yuan, Bo Yan, Xiaoming Zhang, Fei Liang, Jian Zhou, Jia Fan, Yong Zeng, Muyan Cai, Qiang Gao	144
9	The influence of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on the N- and M-staging and subsequent clinical management of intrahepatic cholangiocarcinoma 2021 ·HepatoBiliary Surgery and Nutrition ·Youpei Lin, Huanhuan Chong, Guohe Song, Chenhao Zhang, Liangqing Dong, (unknown), Fei Liang, Shuaixi Yang, Mengsu Zeng, Guangyu Ding, Shu Zhang, Jie-Yi Shi, Ai‐Wu Ke, Xiaoying Wang, Jian Zhou, Jia Fan, Qiang Gao	7
10	Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma 2019 ·Clinical Cancer Research ·Meng Duan, Shyamal Goswami, Jie-Yi Shi, (unknown), Xiaoying Wang, Jiaqiang Ma, Zhao Zhang, Yang Shi, Lijie Ma, Shu Zhang, Ruibin Xi, Ya Cao, Jian Zhou, Jia Fan, Xiaoming Zhang, Qiang Gao	114
11	Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients 2018 ·BMC Cancer ·Bohao Zheng, Long-Zi Liu, Zhizhi Zhang, Jie-Yi Shi, Liangqing Dong, Lingyu Tian, Zhen‐Bin Ding, Yuan Ji, Shengxiang Rao, Jian Zhou, Jia Fan, Xiaoying Wang, Qiang Gao	113
12	Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing 2018 ·Cell Research ·Meng Duan, Junfeng Hao, Sijia Cui, Daniel L. Worthley, Shu Zhang, Zhichao Wang, Jie-Yi Shi, Longzi Liu, Xiaoying Wang, Ai‐Wu Ke, Ya Cao, Ruibin Xi, Xiaoming Zhang, Jian Zhou, Jia Fan, Chong Li, Qiang Gao	97
13	FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway 2017 ·BMC Cancer ·Jie-Yi Shi, Lijie Ma, Jiwei Zhang, Meng Duan, Zhen‐Bin Ding, Liu‐Xiao Yang, Ya Cao, Jian Zhou, Jia Fan, Xiaoming Zhang, Yingjun Zhao, Xiaoying Wang, Qiang Gao	42
14	Genetic polymorphisms of the multidrug resistance 1 gene MDR1 and the risk of hepatocellular carcinoma 2015 ·Tumor Biology ·Zhichao Wang, Long-Zi Liu, (unknown), Jinjing Hu, Yong-Na Wu, Jie-Yi Shi, Liu‐Xiao Yang, Meng Duan, Xiaoying Wang, Jian Zhou, Jia Fan, Qiang Gao	7
15	TREM-1, an Inflammatory Modulator, is Expressed in Hepatocellular Carcinoma Cells and Significantly Promotes Tumor Progression 2014 ·Annals of Surgical Oncology ·Meng Duan, Zhichao Wang, Xiaoying Wang, Jie-Yi Shi, Liu‐Xiao Yang, (unknown), Qiang Gao, Jian Zhou, Jia Fan	46
16	RANKL Promotes Migration and Invasion of Hepatocellular Carcinoma Cells via NF-κB-Mediated Epithelial-Mesenchymal Transition 2014 ·PLoS ONE ·(unknown), Meng Duan, Long-Zi Liu, Zhichao Wang, Jie-Yi Shi, Liu‐Xiao Yang, Jian Zhou, Jia Fan, Qiang Gao, Xiaoying Wang	33
17	Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma 2013 ·Clinical Cancer Research ·Jie-Yi Shi, Qiang Gao, Zhichao Wang, Jian Zhou, Xiaoying Wang, Zhihui Min, Ying‐Hong Shi, Guo‐Ming Shi, Zhen‐Bin Ding, Ai‐Wu Ke, Zhi Dai, Shuang‐Jian Qiu, Kang Song, Jia Fan	182
18	Genetic Polymorphism of the Kinesin-Like Protein KIF1B Gene and the Risk of Hepatocellular Carcinoma 2013 ·PLoS ONE ·Zhichao Wang, Qiang Gao, Jie-Yi Shi, Liu‐Xiao Yang, Jian Zhou, Xiaoying Wang, Yongyong Shi, Ai‐Wu Ke, Guo‐Ming Shi, Zhen‐Bin Ding, Zhi Dai, Shuang–Jian Qiu, Jia Fan	20
19	CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma 2012 ·Cancer Research ·Qiang Gao, Yingjun Zhao, Xiaoying Wang, Shuang–Jian Qiu, Yongyong Shi, Jian Sun, Yong Yi, Jie-Yi Shi, Guo‐Ming Shi, Zhen‐Bin Ding, Yongsheng Xiao, Zhonghua Zhao, Jian Zhou, Xianghuo He, Jia Fan	136
20	B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence 2012 ·Cancer Immunology Immunotherapy ·(unknown), Qiang Gao, Shuang‐Jian Qiu, Jian Zhou, Xiaoying Wang, Yong Yi, Jie-Yi Shi, Yongfeng Xu, Ying‐Hong Shi, Kang Song, Yong‐Sheng Xiao, Jia Fan	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact